Holen Sie sich die Stockscreener-App
32.08
9.83%
2.87
Handel nachbörslich:
31.55
-0.53
-1.65%
Schlusskurs vom Vortag:
$29.21
Offen:
$29.72
24-Stunden-Volumen:
960.99K
Relative Volume:
1.12
Marktkapitalisierung:
$1.47B
Einnahmen:
$656.32M
Nettoeinkommen (Verlust:
$-164.17M
KGV:
-10.77
EPS:
-2.9794
Netto-Cashflow:
$12.90M
1W Leistung:
+12.96%
1M Leistung:
-4.15%
6M Leistung:
-28.88%
1J Leistung:
-40.93%
1-Tages-Spanne:
$29.61
$32.26
1-Wochen-Bereich:
$27.95
$32.26
52-Wochen-Spanne:
$23.91
$55.63
Azenta Inc Stock (AZTA) Company Profile
Firmenname
Azenta Inc
Sektor
Telefon
(978) 262-2400
Adresse
200 SUMMIT DRIVE, BURLINGTON
Vergleichen Sie AZTA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AZTA
Azenta Inc
|
32.08 | 1.34B | 656.32M | -164.17M | 12.90M | -2.9794 |
|
ISRG
Intuitive Surgical Inc
|
482.35 | 171.42B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
195.96 | 55.88B | 21.39B | 1.59B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
86.48 | 42.55B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
288.28 | 41.48B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
246.22 | 17.25B | 2.90B | 467.20M | 306.90M | 6.37 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-07-22 | Fortgesetzt | Stephens | Equal-Weight |
| 2024-12-18 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2024-04-04 | Eingeleitet | Jefferies | Hold |
| 2024-02-01 | Bestätigt | B. Riley Securities | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Mkt Perform |
| 2023-05-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-02-09 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-03-31 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-03-21 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Azenta Inc Aktie (AZTA) Neueste Nachrichten
Can Azenta’s (AZTA) Genomics Partnership Reframe Its Long-Term Growth Story? - simplywall.st
Azenta EVP Lin buys $69,900 in shares By Investing.com - Investing.com Australia
Azenta EVP Lin buys $69,900 in shares - Investing.com
Revvity, Avantor, Azenta, Bio-Techne, and Amneal Shares Skyrocket, What You Need To Know - TradingView
How to forecast Azenta Inc. trends using time seriesStock Entry Point Planner with Volume Spike - Newser
Smart tools for monitoring Azenta Inc.’s price actionFree Earnings Play Trade Plan With Alerts - Newser
Has Azenta Inc. formed a bullish divergenceMulti-Year Investment Performance Summary Report - Newser
Volume spikes in Azenta Inc. stock – what they meanTechnical Entry Plan with Risk Minimization - Newser
New Product Launches: Will They Boost Azenta Inc. Stock in 2025Bear Market Safe Zone Technical Analysis - Newser
Azenta upgraded to Outperform from Market Perform at Raymond James - MSN
What makes Azenta Inc. stock price move sharplyHigh Return in Low Timeframe - thegnnews.com
Visual analytics tools that track Azenta Inc. performanceRisk Aware Trading Ideas with Alert Levels - Newser
Should I trade or invest in Azenta Inc.Big Money Stock Playbook - mustnews.co.kr
Raymond James Financial Upgrades Azenta (NASDAQ:AZTA) to “Outperform” - Defense World
Evercore ISI Reiterates “$33.00” Price Target for Azenta (NASDAQ:AZTA) - Defense World
Why Azenta (AZTA) Stock Is Up Today - TradingView
Azenta 2025 Q3 Earnings Deepening Losses Amid Flat Revenue - AInvest
Azenta, Inc. (NASDAQ:AZTA) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates - simplywall.st
Evercore ISI Has Lowered Expectations for Azenta (NASDAQ:AZTA) Stock Price - Defense World
Azenta (NASDAQ:AZTA) Trading 8.8% Higher on Strong Earnings - Defense World
Azenta Inc Q3 2025 Earnings Call Highlights: Robust Financial Position Amid Revenue Challenges - AInvest
Azenta, Inc. Earnings Call: Balancing Growth and Challenges - The Globe and Mail
Optimistic Buy Rating for Azenta: Margin Improvements and Market Potential Highlighted - TipRanks
Azenta reaffirms 3%–5% organic growth and 300bps margin expansion for 2025 as operational turnaround advances - MSN
Azenta, Inc. SEC 10-Q Report - TradingView
Azenta (AZTA) Stock Trades Up, Here Is Why - TradingView
Azenta, Inc. (NASDAQ:AZTA) Q3 2025 Earnings Call Transcript - Insider Monkey
Raymond James Upgrades Azenta to Outperform From Market Perform - MarketScreener
Azenta's Q3 2025 Earnings Call: Unpacking Contradictions in NIH Funding, Growth Projections, and Market Dynamics - AInvest
Azenta stock upgraded to Outperform by Raymond James on margin improvement - Investing.com
Azenta Inc (AZTA) Q3 2025 Earnings Call Highlights: Strong Financial Position Amid Revenue ... By GuruFocus - Investing.com Canada
Azenta (NASDAQ:AZTA) Shares Gap Down After Analyst Downgrade - Defense World
Azenta, Inc. Reports Steady Q3 2025 Earnings - TipRanks
Can Azenta Inc. recover in the next quarterFree High Yield Stock Screening Results - Newser
Azenta's Q3 2025 Earnings Call: Dissecting Contradictions in Revenue Growth, Leadership Changes, and NGS Momentum - AInvest
Azenta's Q3 2025 Earnings and Strategic Position in the Gene Therapy Market: A Deep Dive into Growth Catalysts and Financial Resilience - AInvest
Azenta, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:AZTA) - Seeking Alpha
Why Azenta (AZTA) Stock Is Trading Lower Today - TradingView
Earnings call transcript: Azenta’s Q3 2025 earnings beat EPS expectations - Investing.com
Evercore ISI lowers Azenta stock price target to $33 on order delays - Investing.com Canada
Azenta (NASDAQ:AZTA) Misses Q2 Sales Targets - TradingView
Azenta earnings beat by $0.06, revenue fell short of estimates - Investing.com UK
Earnings Flash (AZTA) Azenta, Inc. Reports Q3 Revenue $143.9M, vs. FactSet Est of $149.4M - MarketScreener
Earnings Flash (AZTA) Azenta, Inc. Posts Q3 Adjusted EPS $0.19 per Share - MarketScreener
Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance - PR Newswire
Cwm LLC Sells 1,028 Shares of Azenta, Inc. (NASDAQ:AZTA) - Defense World
Using flow based indicators on Azenta Inc.Swing Trade Planning with Consistent Setup - Newser
Chart overlay techniques for tracking Azenta Inc.Real Trader Watchlist with Entry Targets - Newser
Azenta Inc. Inches Above Key Support — Safe to HoldEntry Plan for Oversold Reversal Stocks Released - beatles.ru
What the charts say about Azenta Inc. todayPredictable Return Strategy with AI Support - Newser
Short interest data insights for Azenta Inc.Daily Swing Candidate Analysis with Chart Patterns - Newser
Finanzdaten der Azenta Inc-Aktie (AZTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Azenta Inc-Aktie (AZTA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Hughes Violetta | VP, Chief Accounting Officer |
Feb 03 '25 |
Sale |
52.97 |
317 |
16,791 |
9,603 |
| Zhou Ginger | SVP and General Manager, Genom |
Jan 31 '25 |
Buy |
45.88 |
417 |
19,132 |
27,916 |
| Pirogova Olga | SVP and CHRO |
Nov 19 '24 |
Sale |
40.07 |
548 |
21,958 |
19,373 |
| Hughes Violetta | VP, Chief Accounting Officer |
Nov 19 '24 |
Sale |
40.07 |
163 |
6,531 |
9,920 |
| Zhou Ginger | SVP and General Manager, Genom |
Nov 19 '24 |
Sale |
40.07 |
491 |
19,674 |
27,499 |
| Wang David Dong | SVP & GM, SMS |
Nov 19 '24 |
Sale |
40.07 |
348 |
13,944 |
24,114 |
| Joseph Jason | SVP, General Counsel, Secy. |
Nov 19 '24 |
Sale |
40.07 |
1,139 |
45,640 |
112,564 |
| Cueto Herman | EVP, Chief Financial Officer |
Nov 19 '24 |
Sale |
40.07 |
712 |
28,530 |
23,892 |
| Marotta John | President and CEO |
Nov 18 '24 |
Buy |
39.48 |
12,717 |
502,066 |
99,612 |
| Marotta John | President and CEO |
Nov 19 '24 |
Buy |
40.67 |
1,250 |
50,838 |
100,862 |
3.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):